Matches in Nanopublications for { ?s ?p "[This Phase I study, 'Ribozyme Gene Therapy of HIV-1 Infection' (UCSD HSC #971072, FDA BB-IND 6405), is a prospective, open-label trial of infusion of autologous gene-altered cells into asymptomatic HIV-1 seropositive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP414417.RAwc4VFC9FvO55ZyB0HIPo4VmkBFuJs6VIavj4wFOJTBo130_assertion description "[This Phase I study, 'Ribozyme Gene Therapy of HIV-1 Infection' (UCSD HSC #971072, FDA BB-IND 6405), is a prospective, open-label trial of infusion of autologous gene-altered cells into asymptomatic HIV-1 seropositive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414417.RAwc4VFC9FvO55ZyB0HIPo4VmkBFuJs6VIavj4wFOJTBo130_provenance.
- assertion description "[This Phase I study, 'Ribozyme Gene Therapy of HIV-1 Infection' (UCSD HSC #971072, FDA BB-IND 6405), is a prospective, open-label trial of infusion of autologous gene-altered cells into asymptomatic HIV-1 seropositive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP414510.RAGvQA_IcMJAROjzxoNlkTvIznMmGFMPnYn4-bjz-IAK8130_assertion description "[This Phase I study, 'Ribozyme Gene Therapy of HIV-1 Infection' (UCSD HSC #971072, FDA BB-IND 6405), is a prospective, open-label trial of infusion of autologous gene-altered cells into asymptomatic HIV-1 seropositive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414510.RAGvQA_IcMJAROjzxoNlkTvIznMmGFMPnYn4-bjz-IAK8130_provenance.